5 Year Outcomes In Patients Undergoing Phacoemulsification With Single Istent Implantation (First Generation Istent®, Glaukos Corporation, California) In Comparison To Phaco Alone In A Tertiary Referral Centre With A Diverse Multi-Ethnic Population

Published 2023 - 41st Congress of the ESCRS

Reference: PP23.10 | Type: Free paper | DOI: 10.82333/map8-hg93